Top

Published in:

01-04-2004 | Case Report

Successful treatment of µ-heavy chain disease with fludarabine monophosphate: A case report

Authors: Machi Yanai, Akinori Maeda, Naoko Watanabe, Naoshi Sugimoto, Akiko Matsushita, Kenichi Nagai, Tatsuo Oida, Takayuki Takahashi

Published in: International Journal of Hematology | Issue 2/2004

Title: Successful treatment of µ-heavy chain disease with fludarabine monophosphate: A case report
Authors: Machi Yanai
Akinori Maeda
Naoko Watanabe
Naoshi Sugimoto
Akiko Matsushita
Kenichi Nagai
Tatsuo Oida
Takayuki Takahashi
Publication date: 01-04-2004
Publisher: Springer-Verlag
Published in: International Journal of Hematology / Issue 2/2004
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI: https://doi.org/10.1532/IJH97.03053

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2004

Successful unrelated donor bone marrow transplantation for shwachman-diamond syndrome with leukemia

Progress in the understanding of protease-activated receptors

Quantitative assessment of disease involvement by follicular lymphoma using real-time polymerase chain reaction measurement of t(14;18)-carrying cells

Primary adult T-Cell leukemia/lymphoma of bone

The TEL/ARG leukemia oncogene promotes viability and hyperresponsiveness to hematopoietic growth factors

Bone marrow hypoplasia complicating tacrolimus (FK506) therapy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer